• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于癌症免疫治疗的免疫佐剂向肿瘤浸润树突状细胞的可编程递送

Programmable Delivery of Immune Adjuvant to Tumor-Infiltrating Dendritic Cells for Cancer Immunotherapy.

作者信息

Liu Jing, Li Hong-Jun, Luo Ying-Li, Chen Yi-Fang, Fan Ya-Nan, Du Jin-Zhi, Wang Jun

机构信息

Guangzhou First People's Hospital, School of Biomedical Sciences and Engineering, Guangzhou International Campus, South China University of Technology, Guangzhou 510006, P. R. China.

School of Life Sciences, University of Science and Technology of China, Hefei, Anhui 230027, P. R. China.

出版信息

Nano Lett. 2020 Jul 8;20(7):4882-4889. doi: 10.1021/acs.nanolett.0c00893. Epub 2020 Jun 23.

DOI:10.1021/acs.nanolett.0c00893
PMID:32551705
Abstract

Tumor-infiltrating dendritic cells (TIDCs) are mostly immature and immunosuppressive, usually mediating immune inhibition. The utilization of cytosine-guanine oligodeoxynucleotides (CpG ODNs) to stimulate the activation of TIDCs has been demonstrated to be effective for improving antitumor immunity. However, a series of biological barriers has limited the efficacy of previous nanocarriers for delivering CpG to TIDCs. Herein, we developed a dual-sensitive dendrimer cluster-based nanoadjuvant for delivering CpG ODNs into TIDCs. We show that the tumor acidity triggers the rapid release of CpG conjugated polyamidoamine (PAMAM) dendrimers from the nanoadjuvant, thus facilitating its perfusion deep into tumors and phagocytosis by TIDCs. Thereafter, the reductive condition of the endolysosomes led to the subsequent release of CpG, which promotes the DCs activation and enhances antitumor immunotherapies. Programmable delivery of immune adjuvant efficiently overcomes the barriers for targeted delivery to TIDCs and provides a promising strategy for improving cancer immunotherapy.

摘要

肿瘤浸润性树突状细胞(TIDCs)大多不成熟且具有免疫抑制作用,通常介导免疫抑制。利用胞嘧啶-鸟嘌呤寡脱氧核苷酸(CpG ODNs)刺激TIDCs的活化已被证明对提高抗肿瘤免疫力有效。然而,一系列生物学障碍限制了先前纳米载体将CpG递送至TIDCs的功效。在此,我们开发了一种基于双敏感树枝状聚合物簇的纳米佐剂,用于将CpG ODNs递送至TIDCs。我们表明,肿瘤酸性环境触发纳米佐剂中与CpG偶联的聚酰胺-胺(PAMAM)树枝状聚合物的快速释放,从而促进其深入肿瘤灌注并被TIDCs吞噬。此后,内溶酶体的还原环境导致CpG随后释放,这促进了树突状细胞的活化并增强了抗肿瘤免疫疗法。免疫佐剂的可编程递送有效克服了靶向递送至TIDCs的障碍,并为改善癌症免疫疗法提供了一种有前景的策略。

相似文献

1
Programmable Delivery of Immune Adjuvant to Tumor-Infiltrating Dendritic Cells for Cancer Immunotherapy.用于癌症免疫治疗的免疫佐剂向肿瘤浸润树突状细胞的可编程递送
Nano Lett. 2020 Jul 8;20(7):4882-4889. doi: 10.1021/acs.nanolett.0c00893. Epub 2020 Jun 23.
2
Hydrogel/nanoadjuvant-mediated combined cell vaccines for cancer immunotherapy.水凝胶/纳米佐剂介导的联合细胞疫苗用于癌症免疫治疗。
Acta Biomater. 2021 Oct 1;133:257-267. doi: 10.1016/j.actbio.2021.08.014. Epub 2021 Aug 15.
3
Small EV-based delivery of CpG ODNs for melanoma postsurgical immunotherapy.基于小细胞外囊泡的 CpG ODN 用于黑色素瘤术后免疫治疗。
J Control Release. 2023 Nov;363:484-495. doi: 10.1016/j.jconrel.2023.07.065. Epub 2023 Oct 6.
4
Carbonate Apatite Nanoparticles Act as Potent Vaccine Adjuvant Delivery Vehicles by Enhancing Cytokine Production Induced by Encapsulated Cytosine-Phosphate-Guanine Oligodeoxynucleotides.碳酸磷灰石纳米颗粒通过增强包裹的胞嘧啶-磷酸-鸟嘌呤寡脱氧核苷酸诱导的细胞因子产生,充当有效的疫苗佐剂递送载体。
Front Immunol. 2018 Apr 18;9:783. doi: 10.3389/fimmu.2018.00783. eCollection 2018.
5
Efficient TNBC immunotherapy by dual reprogramming tumor-infiltrating dendritic cells and tumor-associated macrophages with stimulus-responsive miR155 nanocomplexes.通过用刺激响应性miR155纳米复合物双重重编程肿瘤浸润树突状细胞和肿瘤相关巨噬细胞实现三阴性乳腺癌的高效免疫治疗
Int J Biol Macromol. 2023 Dec 31;253(Pt 3):126912. doi: 10.1016/j.ijbiomac.2023.126912. Epub 2023 Sep 16.
6
Adoptive cellular immunotherapy of tumors via effective CpG delivery to dendritic cells using dendrimer-entrapped gold nanoparticles as a gene vector.通过使用树枝状聚合物包埋的金纳米粒子作为基因载体,将有效的 CpG 递送至树突状细胞,对肿瘤进行过继细胞免疫治疗。
J Mater Chem B. 2020 Jun 21;8(23):5052-5063. doi: 10.1039/d0tb00678e. Epub 2020 May 13.
7
Aminated yeast β-D-glucan for macrophage-targeted delivery of CpG oligodeoxynucleotides and synergistically enhanced cancer immunotherapy.载 CpG 寡脱氧核苷酸的氨基化酵母 β-D-葡聚糖用于巨噬细胞靶向递药及协同增强癌症免疫治疗
Int J Biol Macromol. 2023 Dec 31;253(Pt 3):126998. doi: 10.1016/j.ijbiomac.2023.126998. Epub 2023 Sep 18.
8
Glycogen for lysosome-targeted CpG ODNs delivery and enhanced cancer immunotherapy.用于溶酶体靶向 CpG ODN 传递和增强癌症免疫治疗的糖原。
Int J Biol Macromol. 2024 Feb;257(Pt 1):128536. doi: 10.1016/j.ijbiomac.2023.128536. Epub 2023 Dec 5.
9
Targeted delivery of let-7b to reprogramme tumor-associated macrophages and tumor infiltrating dendritic cells for tumor rejection.靶向递送 let-7b 以重新编程肿瘤相关巨噬细胞和肿瘤浸润树突状细胞以排斥肿瘤。
Biomaterials. 2016 Jun;90:72-84. doi: 10.1016/j.biomaterials.2016.03.009. Epub 2016 Mar 9.
10
An Adjuvant Micelle-Based Multifunctional Nanosystem for Tumor Immunotherapy by Remodeling Three Types of Immunosuppressive Cells.一种基于辅助胶束的多功能纳米系统,通过重塑三种免疫抑制细胞用于肿瘤免疫治疗。
ACS Nano. 2024 Jan 30;18(4):3134-3150. doi: 10.1021/acsnano.3c08792. Epub 2024 Jan 18.

引用本文的文献

1
Precise In Situ Delivery of a Photo-Enhanceable Inflammasome-Activating Nanovaccine Activates Anticancer Immunity.精确原位递送光增强型炎症小体激活纳米疫苗可激活抗肿瘤免疫。
Cancer Res. 2024 Nov 15;84(22):3834-3847. doi: 10.1158/0008-5472.CAN-24-0220.
2
Metal-Organic Frameworks Applications in Synergistic Cancer Photo-Immunotherapy.金属有机框架在协同癌症光免疫治疗中的应用
Polymers (Basel). 2023 Mar 16;15(6):1490. doi: 10.3390/polym15061490.
3
Emerging Sonodynamic Therapy-Based Nanomedicines for Cancer Immunotherapy.基于声动力学疗法的新兴纳米医学用于癌症免疫治疗。
Adv Sci (Weinh). 2023 Jan;10(2):e2204365. doi: 10.1002/advs.202204365. Epub 2022 Nov 27.
4
Nanodrug enhances post-ablation immunotherapy of hepatocellular carcinoma via promoting dendritic cell maturation and antigen presentation.纳米药物通过促进树突状细胞成熟和抗原呈递增强肝癌消融后免疫治疗。
Bioact Mater. 2022 Aug 14;21:57-68. doi: 10.1016/j.bioactmat.2022.07.027. eCollection 2023 Mar.
5
Optimized Cationic Lipid-assisted Nanoparticle for Delivering CpG Oligodeoxynucleotides to Treat Hepatitis B Virus Infection.优化阳离子脂质体辅助纳米颗粒递送至治疗乙型肝炎病毒感染。
Pharm Res. 2023 Jan;40(1):145-156. doi: 10.1007/s11095-022-03307-w. Epub 2022 Aug 24.
6
Optimized mobilization of MHC class I- and II- restricted immunity by dendritic cell vaccine potentiates cancer therapy.树突状细胞疫苗增强 MHC Ⅰ类和Ⅱ类限制性免疫的优化动员可增强癌症治疗效果。
Theranostics. 2022 Apr 24;12(7):3488-3502. doi: 10.7150/thno.71760. eCollection 2022.
7
Nucleic acid and oligonucleotide delivery for activating innate immunity in cancer immunotherapy.核酸和寡核苷酸在癌症免疫治疗中激活固有免疫的递送。
J Control Release. 2022 May;345:586-600. doi: 10.1016/j.jconrel.2022.03.045. Epub 2022 Mar 26.
8
Stimuli-Responsive Polymeric Nanomaterials for the Delivery of Immunotherapy Moieties: Antigens, Adjuvants and Agonists.刺激响应型聚合物纳米材料用于免疫治疗药物的递送:抗原、佐剂和激动剂。
Int J Mol Sci. 2021 Nov 19;22(22):12510. doi: 10.3390/ijms222212510.
9
The expression and clinical value of tumor infiltrating dendritic cells in tumor tissues of patients with esophageal cancer.肿瘤浸润性树突状细胞在食管癌患者肿瘤组织中的表达及临床价值
J Gastrointest Oncol. 2021 Oct;12(5):1996-2003. doi: 10.21037/jgo-21-578.
10
Engineering Therapeutic Strategies in Cancer Immunotherapy via Exogenous Delivery of Toll-like Receptor Agonists.通过 Toll 样受体激动剂的外源递送构建癌症免疫治疗的策略
Pharmaceutics. 2021 Aug 31;13(9):1374. doi: 10.3390/pharmaceutics13091374.